These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23530732)

  • 21. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
    Leuchter AF; Cook IA; Marangell LB; Gilmer WS; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; McCracken JT; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):124-31. PubMed ID: 19712979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
    Ji Y; Hebbring S; Zhu H; Jenkins GD; Biernacka J; Snyder K; Drews M; Fiehn O; Zeng Z; Schaid D; Mrazek DA; Kaddurah-Daouk R; Weinshilboum RM
    Clin Pharmacol Ther; 2011 Jan; 89(1):97-104. PubMed ID: 21107318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants and their effect on cognition in major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2015 Aug; 76(8):e1046. PubMed ID: 26335095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
    Eyre HA; Eskin A; Nelson SF; St Cyr NM; Siddarth P; Baune BT; Lavretsky H
    Int J Geriatr Psychiatry; 2016 May; 31(5):510-7. PubMed ID: 26471432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.
    Barakat AK; Scholl C; Steffens M; Brandenburg K; Ising M; Lucae S; Holsboer F; Laje G; Kalayda GV; Jaehde U; Stingl JC
    Transl Psychiatry; 2020 Jul; 10(1):210. PubMed ID: 32612257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
    Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
    Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder.
    Korgaonkar MS; Goldstein-Piekarski AN; Fornito A; Williams LM
    Mol Psychiatry; 2020 Jul; 25(7):1537-1549. PubMed ID: 31695168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectories of individual symptoms in remitters versus non-remitters with depression.
    Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
    J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
    Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
    J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and functional outcomes of patients who experience partial response to citalopram: secondary analysis of STAR*D.
    Dennehy EB; Marangell LB; Martinez J; Balasubramani GK; Wisniewski SR
    J Psychiatr Pract; 2014 May; 20(3):178-87. PubMed ID: 24847991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
    Zwicker A; Fabbri C; Rietschel M; Hauser J; Mors O; Maier W; Zobel A; Farmer A; Aitchison KJ; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2018 Oct; 105():17-22. PubMed ID: 30130674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.
    Qin S; Eugene AR; Liu D; Zhang L; Neavin D; Biernacka JM; Yu J; Weinshilboum RM; Wang L
    Clin Pharmacol Ther; 2020 Mar; 107(3):662-670. PubMed ID: 31628858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients.
    El-Hage W; Vourc'h P; Gaillard P; Léger J; Belzung C; Ibarguen-Vargas Y; Andres CR; Camus V
    Psychopharmacology (Berl); 2015 Feb; 232(3):575-81. PubMed ID: 25074447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
    Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
    Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.